BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for April 2, 2026

April 2, 2026
New hires and promotions in the biopharma and med-tech industries, including: Aavantgarde, Airos, Alloy, Ardelyx, Bayer, Bruker, Corwave, Evotec, Expres2ion, Femasys, Mosaic, Nanoscope, Nocion, Orionis and Zymeworks.
Read More

Appointments and advancements for April 1, 2026

April 1, 2026
New hires and promotions in the biopharma and med-tech industries, including: Immunic, Inogen, Kalohexis, Onconetix, Proxygen, Reset Health, Science Corp., Stryker, Telo Genomics.
Read More

Appointments and advancements for March 31, 2026

March 31, 2026
New hires and promotions in the biopharma and med-tech industries, including: Adarx, Biomx, Cue, Novavax, Transcenta.
Read More

Appointments and advancements for March 30, 2026

March 30, 2026
New hires and promotions in the biopharma and med-tech industries, including: Beyond Air, Galapagos, Sonorous, Xaira.
Read More

Appointments and advancements for March 27, 2026

March 27, 2026
New hires and promotions in the biopharma and med-tech industries, including: Averna, Braveheart, Concert AI, Crossject, Faron, Geron, Humacyte, Ligand, Plus, Prokidney, Rani, Sironax.
Read More

Appointments and advancements for March 26, 2026

March 26, 2026
New hires and promotions in the biopharma and med-tech industries, including: Incyte, Mirzyme, PTC, Vera.
Read More

Appointments and advancements for March 25, 2026

March 25, 2026
New hires and promotions in the biopharma and med-tech industries, including: A3P, Abivax, Adrax, Altathera, Camp4, Icecure, Idel, Leapfrog, Mentice, Mineralys, Over T, Protillion, Quidelortho, Realta, Umoja.
Read More

Appointments and advancements for March 24, 2026

March 24, 2026
New hires and promotions in the biopharma and med-tech industries, including: Anaveon, Aurinia, Biostem, Cardinal, Damora, Palvella, Persica.
Read More

Appointments and advancements for March 24, 2026

March 24, 2026
New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Harbour Biomed.
Read More

Appointments and advancements for March 23, 2026

March 23, 2026
New hires and promotions in the biopharma and med-tech industries, including: Aquestive, Genmab, Kaida, Repronovo.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 323 324 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing